Total investment banking net revenues at Jefferies jumped 20.3% to $1.14 billion compared to the previous year. Advisory ...

If the Fed continues to cut in line with market expectations and the RBA holds it will see the Fed Funds rate fall well below the RBA’s cash rate possibly putting substantial upwards pressure on the ...

Uscom Limited (ASX: USM), an Australian medical device company focusing on non-invasive cardiovascular and pulmonary monitoring technologies, has announced it has entered into an agreement to sell its ...

Sept 2025 - Company also announces manufacturing agreement with Northrop Grumman and Level 1 accreditation with Huntington Ingalls ...

Soul Pattinson and Company Limited (ASX:SOL), a diversified investment house, today released an investor presentation following the implementation of its merger with Brickworks Limited. Soul Patts has ...

Billionaire Kerry Stokes has announced his intention to step down as chairman of Seven West Media if the proposed merger with Southern Cross Austereo proceeds successfully. The merger, unveiled on ...

Two resource companies, Saturn Metals and James Bay Minerals, have launched capital raising initiatives, capitalising on the recent rally in gold prices. These moves aim to bolster exploration efforts ...

The agreement commits AGL to purchasing 45 per cent of the electricity output from the 288-megawatt Palmer wind farm, which is located approximately 70km east of Adelaide. The project is anticipated ...

The Kwinana refinery has been mothballed since June 2024. Alcoa stated that the decision to permanently close the plant was made after determining that the facility’s age, operating costs, low bauxite ...

Lakes Blue Energy (ASX: LKO) has announced the completion of drilling operations at the Wombat-5, side-track-2 (ST-2) well in the Gippsland Basin, Victoria. Lakes Blue Energy is focused on the ...

Sept 2025 - ASX-listed company forecasts revenue exceeding $114 million and uEBITDA between $12.6 million and $13.6 million.

Under the terms of the agreement, Starpharma will receive R&D service and manufacturing fees for its work, which commences immediately. Radiopharm will be granted an exclusive option to license the ...